ArticleESC heart failure2021
Hospitalizations for heart failure: still major differences between East and West Germany 30 years after reunification.
Article in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Bridging the post-hospitalization gap: a feasibility study of home-based rehabilitation in decompensated heart failure.ESC heart failure · 2026Trial
- Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction.ESC heart failure · 2026Observational
- Rationale and design of the randomized 'early ventricular assist device'-Trial (VAD-DZHK3).ESC heart failure · 2025Article
- Congestion assessment using a self-supervised contrastive learning-derived risk index in patients with congestive heart failure (CONAN): protocol and design of a prospective cohort study.European heart journal. Digital health · 2025Article
- Lower ambulatory care availability and greater hospital capacity are associated with higher hospital case volumes.Research in health services & regions · 2025Article
- Poor communication impairs optimal care of patients with heart failure and erectile dysfunction.ESC heart failure · 2025Article
- Vocal biomarkers in heart failure-design, rationale and baseline characteristics of the AHF-Voice study.Frontiers in digital health · 2025Article
- The Cold War in pharmacology: a bibliometric analysis of Berlin's contributions to Naunyn‑Schmiedeberg's Archives of Pharmacology (1947-1974).Naunyn-Schmiedeberg's archives of pharmacology · 2024Article
- Real-world characteristics and use patterns of patients treated with vericiguat: A nationwide longitudinal cohort study in Germany.European journal of clinical pharmacology · 2024Article
- Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis.The Lancet regional health. Europe · 2023Article
- Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018.Clinical research in cardiology : official journal of the German Cardiac Society · 2023Article
- A practical approach to the guideline-directed pharmacological treatment of heart failure with reduced ejection fraction.ESC heart failure · 2023Review
- Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials.ESC heart failure · 2022Review
- Review
- Hospitalizations for heart failure: still major differences between East and West Germany 30 years after reunification.ESC heart failure · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsHeart failure (HF) is the most common primary inpatient diagnosis in Germany. We examined temporal trends of HF hospitalization within Germany focusing on regional differences. METHODS AND
resultsWe analysed aggregated data of more than 320 million hospitalizations in Germany from 2000 to 2017. Temporal trends of HF-related parameters were analysed, focusing on regional differences between the federal states. The absolute number of HF-related hospitalizations throughout Germany increased continuously and almost doubled (from 239 694 to 464 724 cases, +94%) with the relative increase being higher in East Germany compared with West Germany (119% vs. 88%). These regional differences persisted after age standardization with 609 and 490 cases per 100 000 population, respectively. The length of stay decreased continuously across Germany (from 14.3 to 10.2 days; -29%), while the total number of HF-related hospital days increased by 51% in East Germany and 35% in West Germany. In 2017, HF remained the leading cause of in-hospital death (8.9% of all cases), with a markedly higher rate in East vs. West Germany (65 vs. 43 deaths per 100 000 population).
conclusionsHeart failure remains the most common cause of hospitalization and in-hospital death throughout Germany. The increase in HF-related morbidity and mortality was much higher in East Germany compared with West Germany during the observation period. A more detailed understanding of these striking disparities 30 years after the German reunification requires further investigations. There is an urgent need for action with regard to stronger control of risk factors and improvement of both chronic HF management and healthcare structures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.